Huang Chen, Du Jiawei, Xie Keping
Department of General Surgery, Shanghai Jiaotong University Affiliated First People's Hospital, Shanghai, People's Republic of China; Department of Gastroenterology, Hepatology & Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Department of Laboratory Medicine, Zhenjiang Second People's Hospital, Jiangsu University College of Medicine, Zhenjiang, People's Republic of China.
Biochim Biophys Acta. 2014 Apr;1845(2):104-16. doi: 10.1016/j.bbcan.2014.01.002. Epub 2014 Jan 11.
Pancreatic cancer is a devastating disease with an overall 5-year survival rate less than 5%. Multiple signaling pathways are implicated in the pathogenesis of pancreatic cancer, such as Wnt/β-catenin, Notch, Hedgehog, hypoxia-inducible factor, signal transducer and activator of transcription, specificity proteins/Krüppel-like factors, and Forkhead box (FOX). Recently, increasing evidence has demonstrated that the transcription factor FOXM1 plays important roles in the initiation, progression, and metastasis of a variety of human tumors, including pancreatic cancer. In this review, we focus on the current understanding of the molecular pathogenesis of pancreatic cancer with a special focus on the function and regulation of FOXM1 and rationale for FOXM1 as a novel molecular target for pancreatic cancer prevention and treatment.
胰腺癌是一种极具毁灭性的疾病,其总体5年生存率低于5%。多种信号通路与胰腺癌的发病机制有关,如Wnt/β-连环蛋白、Notch、Hedgehog、缺氧诱导因子、信号转导和转录激活因子、特异性蛋白/Krüppel样因子以及叉头框(FOX)。最近,越来越多的证据表明,转录因子FOXM1在包括胰腺癌在内的多种人类肿瘤的发生、发展和转移中发挥着重要作用。在本综述中,我们重点关注目前对胰腺癌分子发病机制的理解,特别关注FOXM1的功能和调控,以及FOXM1作为胰腺癌预防和治疗新分子靶点的理论依据。